Literature DB >> 17543969

The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist.

Peter E Kima1.   

Abstract

Leishmania are dimorphic protozoan parasites that live as flagellated forms in the gut of their sandfly vector and as aflagellated forms in their mammalian hosts. Although both parasite forms can infect macrophages and dendritic cells, they elicit distinct responses from mammalian cells. Amastigotes are the parasites forms that persist in the infected host; they infect cells recruited to lesions and disseminate the infection to secondary sites. In this review I discuss studies that have investigated the mechanisms that Leishmania amastigotes employ to harness the host cell's response to infection. It should be acknowledged that our understanding of the mechanisms deployed by Leishmania amastigotes to modulate the host cell's response to infection is still rudimentary. Nonetheless, the results show that amastigote interactions with mammalian cells promote the production of anti-inflammatory cytokines such as IL-10 and TGF-beta while suppressing the production of IL-12, superoxide and nitric oxide. An underlying issue that is considered is how these parasites that reside in sequestered vacuolar compartments target host cell processes in the cytosol or the nucleus; does this occur through the release of parasite molecules from parasitophorous vacuoles or by engaging and sustaining signalling pathways throughout the course of infection?

Entities:  

Mesh:

Year:  2007        PMID: 17543969      PMCID: PMC2043126          DOI: 10.1016/j.ijpara.2007.04.007

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  90 in total

Review 1.  Phagocytosis of microbes: complexity in action.

Authors:  David M Underhill; Adrian Ozinsky
Journal:  Annu Rev Immunol       Date:  2001-12-07       Impact factor: 28.527

2.  Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.

Authors:  J Morehead; I Coppens; N W Andrews
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

3.  Neutrophil granulocytes--Trojan horses for Leishmania major and other intracellular microbes?

Authors:  Tamás Laskay; Ger van Zandbergen; Werner Solbach
Journal:  Trends Microbiol       Date:  2003-05       Impact factor: 17.079

Review 4.  Mouse and human dendritic cell subtypes.

Authors:  Ken Shortman; Yong-Jun Liu
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

5.  Leishmania major promastigotes inhibit dendritic cell motility in vitro.

Authors:  Heather Jebbari; Andrew J Stagg; Robert N Davidson; Stella C Knight
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Signalling events involved in interferon-gamma-inducible macrophage nitric oxide generation.

Authors:  Julie Blanchette; Maritza Jaramillo; Martin Olivier
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

7.  Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells.

Authors:  A Ponte-Sucre; D Heise; H Moll
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

8.  Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide.

Authors:  Michael Martin; Robert E Schifferle; Natalia Cuesta; Stefanie N Vogel; Jannet Katz; Suzanne M Michalek
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

Review 9.  Functional aspects of the Leishmania donovani lipophosphoglycan during macrophage infection.

Authors:  Albert Descoteaux; Salvatore J Turco
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

10.  Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation.

Authors:  Alexandre Fontayne; Pham My-Chan Dang; Marie-Anne Gougerot-Pocidalo; Jamel El-Benna
Journal:  Biochemistry       Date:  2002-06-18       Impact factor: 3.162

View more
  49 in total

1.  A structure-activity relationship study of the antimalarial and antileishmanial activities of nonpeptide macrocyclic histone deacetylase inhibitors.

Authors:  William Guerrant; Sandra C Mwakwari; Po C Chen; Shabana I Khan; Babu L Tekwani; Adegboyega K Oyelere
Journal:  ChemMedChem       Date:  2010-08-02       Impact factor: 3.466

2.  Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis.

Authors:  Carolina Gallego; Douglas Golenbock; Maria Adelaida Gomez; Nancy Gore Saravia
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

3.  Leishmania inhibitor of serine peptidase 2 prevents TLR4 activation by neutrophil elastase promoting parasite survival in murine macrophages.

Authors:  Marilia S Faria; Flavia C G Reis; Ricardo L Azevedo-Pereira; Lesley S Morrison; Jeremy C Mottram; Ana Paula C A Lima
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

4.  Synthesis and evaluation of the antileishmanial activity of silver compounds containing imidazolidine-2-thione.

Authors:  Patrícia Ferreira Espuri; Larissa Luiza Dos Reis; Eduardo de Figueiredo Peloso; Vanessa Silva Gontijo; Fábio Antônio Colombo; Juliana Barbosa Nunes; Carine Ervolino de Oliveira; Eduardo T De Almeida; Débora E S Silva; Jessica Bortoletto; Daniel Fonseca Segura; Adelino V G Netto; Marcos José Marques
Journal:  J Biol Inorg Chem       Date:  2019-04-04       Impact factor: 3.358

5.  Fast high yield of pure Leishmania (Leishmania) infantum axenic amastigotes and their infectivity to mouse macrophages.

Authors:  Juliana Dias Costa; Renata Soares; Léa Cysne Finkelstein; Suzana Côrte-Real; Maria de Nazareth Meirelles; Renato Porrozzi
Journal:  Parasitol Res       Date:  2009-03-18       Impact factor: 2.289

6.  Targeted extracellular signal-regulated kinase activation mediated by Leishmania amazonensis requires MP1 scaffold.

Authors:  Paola M Boggiatto; Pedro A Martinez; Ashok Pullikuth; Douglas E Jones; Bryan Bellaire; Andrew Catling; Christine Petersen
Journal:  Microbes Infect       Date:  2014-01-22       Impact factor: 2.700

7.  Cloning, expression and characterisation of a type II cystatin from Schistosoma japonicum, which could regulate macrophage activation.

Authors:  Xiao Yang; Ju Liu; Yuan Yue; Wei Chen; Man Song; Ximei Zhan; Zhongkai Wu
Journal:  Parasitol Res       Date:  2014-08-06       Impact factor: 2.289

8.  Immunological perspectives of leishmaniasis.

Authors:  Susanne Nylén; Shalini Gautam
Journal:  J Glob Infect Dis       Date:  2010-05

Review 9.  Modulation of dendritic cell function by Leishmania parasites.

Authors:  Lynn Soong
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

10.  Influence of parasite encoded inhibitors of serine peptidases in early infection of macrophages with Leishmania major.

Authors:  Sylvain C P Eschenlauer; Marilia S Faria; Lesley S Morrison; Nicolas Bland; Flavia L Ribeiro-Gomes; George A DosReis; Graham H Coombs; Ana Paula C A Lima; Jeremy C Mottram
Journal:  Cell Microbiol       Date:  2008-10-29       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.